Track Rapid Micro Biosystems Inc. Class A Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Rapid Micro Biosystems Inc. Class A Common Stock RPID · Stock Open Rapid Micro Biosystems Inc. Class A Common Stock in new tab

2.57 USD
EPS
-1.12
P/B
0.70
ROE
-45.62
Beta
1.08
Loading chart...
Key Metrics
Earnings dateJuly 31, 2026
EPS-1.12
Book Value1.93
Price to Book0.70
Debt/Equity7.65
% Insiders8.199%
Growth
Revenue Growth0.24%
Estimates
Forward P/E-1.51
Forward EPS-0.89

DCF Valuation

Tweak assumptions to recompute fair value for Rapid Micro Biosystems Inc. Class A Common Stock (RPID)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Rapid Micro Biosystems Inc. Class A Common Stock Logo Rapid Micro Biosystems Inc. Class A Common Stock Analysis (RPID)

United States Health Care Official Website Stock

Is Rapid Micro Biosystems Inc. Class A Common Stock a good investment? Rapid Micro Biosystems Inc. Class A Common Stock (RPID) is currently trading at 2.57 USD.

Earnings Schedule: Rapid Micro Biosystems Inc. Class A Common Stock is expected to release its next earnings report on July 31, 2026. The market consensus estimate for Forward EPS is -0.89.

Investor FAQ

Does Rapid Micro Biosystems Inc. Class A Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Rapid Micro Biosystems Inc. Class A Common Stock?

Rapid Micro Biosystems Inc. Class A Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 31, 2026. The company currently has a trailing EPS of -1.12.

Company Profile

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Exchange Ticker
NMS (United States) RPID
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion